Estimates of measles case fatality ratios: a comprehensive review of community-based studies. by Wolfson, Lara J et al.
Estimates of measles case fatality ratios: a
comprehensive review of community-based
studies
y
Lara J Wolfson,
1* Rebecca F Grais,
2,3,5 Francisco J Luquero,
3 Maureen E Birmingham
4 and
Peter M Strebel
2
Accepted 29 September 2008
Background Global deaths from measles have decreased notably in past decades,
due to both increases in immunization rates and decreases in
measles case fatality ratios (CFRs). While some aspects of the
reduction in measles mortality can be monitored through increases
in immunization coverage, estimating the level of measles deaths
(in absolute terms) is problematic, particularly since incidence-
based methods of estimation rely on accurate measures of measles
CFRs. These ratios vary widely by geographic and epidemiologic
context and even within the same community from year-to-year.
Methods To understand better the variations in CFRs, we reviewed
community-based studies published between 1980 and 2008 report-
ing age-specific measles CFRs.
Results The results of the search consistently document that measles
CFRs are highest in unvaccinated children under age 5 years; in
outbreaks; the lowest CFRs occur in vaccinated children regardless
of setting. The broad range of case and death definitions, study
populations and geography highlight the complexities in extra-
polating results for global public health planning.
Conclusions Values for measles CFRs remain imprecise, resulting in continued
uncertainty about the actual toll measles exacts.
Keywords Measles, community-based studies, case fatality ratio, mortality,
review
Introduction
Although global deaths from measles have decreased
markedly in past decades, largely as a result of
intensive vaccination efforts,
1 estimating the magni-
tude of measles deaths is problematic. Measles case
fatality ratios (CFR) vary widely by geographic and
epidemiologic context and within the same commu-
nity from year-to-year. Current estimates of CFRs
used by the World Health Organization (WHO) in
low-income countries range between 0.05% and 6%.
1,2
In complex emergencies or isolated areas where there
is either low natural immunity or low vaccination
coverage, the CFR is often between 10% and 30%.
3
Little research has explored the epidemiologic data to
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192support these estimates and few comprehensive
studies are reported in the published literature.
As part of the WHO response to the need for more
in-depth information, we reviewed published com-
munity studies conducted between 1980 and 2008
reporting age-specific measles CFRs. This effort adds
to those of others who have examined the global
burden of measles,
1,2,4 but specifically addresses
measles-specific mortality. Our goal was to review
the available data from community studies on
estimates of measles case fatality. We also identified
information gaps and recommend what studies would
help improve our understanding of the burden of
measles and the impact of control measures.
Methods
Search strategy and selection criteria
We searched PubMed/MEDLINE for literature pub-
lished either in English or with an English abstract in a
foreign language publication. Combinations of the
following groups of keywords were used: mortality,
case fatality ratio or rate, community study and mea-
sles. References in published papers were also reviewed
and used to identify other relevant publications. To
avoid inclusion of duplicate studies, publications from
the same region were cross-referenced considering the
place and time period of reported studies.
Only papers published between 1 January 1980 and
1 July 2008, which reported on community-based
studies conducted between 1974 and 2007 were
included. Community in this context is used to indicate
all cases within the specified population, regardless of
where they were identified (i.e. home, health facility or
hospitalized). National studies were included if the
data reported were sufficient to meet the inclusion
criteria described below. We excluded hospital-based
studies as they may represent a biased sample and not
reflect the severity of measles within the community.
5
We also excluded studies reporting on measles out-
breaks in refugee or internally displaced persons camps
as these studies report on specific and unique circum-
stances. Similarly, we excluded studies from indus-
trialized countries with sustained high measles
immunization coverage between 1990 and 2008.
6
We defined a study as a unique analysis of measles
or measles-related CFRs as defined by the authors.
Studies were included if data could be extracted for
two out of three of the following: (i) number of cases;
(ii) number of deaths; and (iii) CFR. We extracted
information on: the country where the study was
conducted, the study site (urban/rural/both), the year
the study began and the year the study ended, study
mid-year, the length of the study, the type of the
study (survey, review or outbreak investigation),
measles case definition and the definition of a
measles or measles-associated death, as well as on
associated risk factors as reported by the study
authors.
As available, the number of measles cases and
deaths in each study was tallied for the following age-
groups: 0–11 months, 12–23 months, 24–35 months,
36–47 months, 48–59 months, 60–119 months and
4120 months. The study sample size was taken to be
the number of measles cases investigated.
Review
First, we provide a descriptive analysis of the studies
by location and study type and review the case
definition, definition of a measles death and case
ascertainment. Second, we explore potential differ-
ences in CFR by study type and setting, studies
reporting no fatalities and studies reporting very high
case fatality (above 15%). We also examined whether
studies addressed potential risk factors for mortality.
These factors included age of infection, secondary vs
primary exposure, infection with complications,
immunization status, gender, vitamin A administra-
tion and nutritional status. The roles of these factors,
the natural history of measles and general epidemiol-
ogic characteristics have been reviewed elsewhere.
7–9
A Kruskal–Wallis test was performed to evaluate
differences in CFR by categories (P<0.05 for chi-
squared with no ties). Results for differences in age
classes in CFR are presented as a notched box plot. In a
notched box plot, the notches represent a robust
estimate of the uncertainty about the medians for
box-to-box comparison. The centre of the notched box
plot is the median, and the endpoints of the notches are
located at the median confidence intervals. The
extreme endpoints of the notched box plot represent
the 25% (lower) and the 75% (upper) quartiles of the
data. When boxes have ‘devil’s ears’ the confidence
intervals surpass the inter-quartile range. Boxes whose
notches do not overlap indicate that the medians of the
two groups differ at the 5% significance level
10).
When information was too inconsistently reported
to perform statistical analyses, no results are pres-
ented. All analyses were performed using R statistical
package R 2.4.0 (The R Project of Statistical
Computing, 2008).
Results
In total, 58 publications were identified, providing 102
different measles studies with sufficient data in
29 countries.
11–68 Table 1 details the included studies
grouped by country and WHO region. One publication
covers 11 countries
11 and includes 18 different
studies. Ten other publications include multiple
studies: 2 studies in Guinea-Bissau,
68 Mozambique,
66
Gambia,
34 India,
46 Senegal,
69 Sri Lanka
44 and
Sudan;
56 3 studies in Niger, Chad and Nigeria;
53 5
and 15 studies in India.
48,49
The time period during which these studies took
place is biased towards the beginning of the period
investigated, with an average study midpoint of
1988.9 (median 1986). The majority occurred in
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CFR (age in months)
WHO
sub
region Country Site
Year
study
started
Study
length
(years) Reference Type
a
Total
cases 411 12–23 24–35 36–47 48–59 60 þ
Other
age Overall
AfrD Burkina Faso Urban 2000 1 Kambire ´ et al.
65 S 2975 2.3 3.6 3.6 3.6 3.6 0.9
(60–179)
0.7
(180þ)
1.50
AfrD Chad Urban 1993 0.8 Ndikuyeze et al.
41 O 824 5.77 8.56 8.89 5.69 4.76 6.73
AfrD Chad Urban 2004 0.5 Grais et al.
53 O 706 6.8 4.7 4.7 1.8 1.8 0.5 2.80
AfrD Gambia Rural 1981 0.9 Hull
35 O 135 14.81
(0–131)
14.81
(0–131)
14.81
(0–131)
14.81
(0–131)
14.81
(0–131)
14.81
(0–131)
14.81
(0–131)
14.81
AfrD Gambia Rural 1981 0 Hull
34 R 146 13.7
(0–131)
13.7
(0–131)
13.7
(0–131)
13.7
(0–131)
13.7
(0–131)
13.7
(0–131)
13.7
(0–131)
13.70
AfrD Gambia Rural 1981 0.9 Hull
35 O 77 63.64 16.67 16.67 16.67 16.67 16.67 40.16
AfrD Gambia Rural 1983 1 Aaby
11 R 132 9.09 9.09 9.09 9.09 9.09 9.09
AfrD Gambia Rural 1984 0.3 Lamb
36 O 54 0 0 0.00
AfrD Gambia Rural 1988 1 Aaby
11 R 54 0 0 0.00
AfrD Ghana Rural 1989 1 Dollimore
30 S 961 21.37 22.86 19.87 19.31 9.33 7.79 16.76
AfrD Ghana All 1996 5 Bosu et al.
64 S 1508 1.2 1.2 1.2 1.2 1.2 0.4 0.90
AfrD Guinea-Bissau All 1979 6 Aaby et al.
13 S 459 27.85 25.56 24.36 9.17 9.17 4.0
(60–119)
28
(120þ)
23.79
AfrD Guinea-Bissau Rural 1979 2.8 Aaby et al.
14 S 162 46.67 52.38 26.92 40 5.26 4.55 11.76 26.79
AfrD Guinea-Bissau Rural 1984 1 Aaby
11 R 162 33.66 33.66 33.66 33.66 33.66 8.2 20.93
AfrD Guinea-Bissau Urban 1980 1 Aaby et al.
15 S 178 20.63 7.41 7.41 11.11 11.11 8.82 11.99
AfrD Guinea-Bissau Urban 1984 3 Aaby et al.
16 S 90 11.11 11.11 11.11
AfrD Guinea-Bissau Urban 1988 1 Aaby
11 O 161 15.32 15.32 15.32 15.32 15.32 10.81 13.07
AfrD Guinea-Bissau Urban 2003 0.75 Martins et al.
68 S8 0
(4–15)
0.00
AfrD Guinea-Bissau Urban 2003 0.75 Martins et al.
68 S 77 0.1
(4–15)
0.09
AfrD Niger Rural 1991 0.7 WER
42 O 528 24.88 24.88 24.88 8.89 8.89 8.89 16.89
AfrD Niger Urban 1991 0.1 Malfait et al.
37 O 258 6.59 6.59 6.59 6.59 6.59 6.59
AfrD Niger Rural 2003 0.4 Nandy et al.
54 O 945 15.7 11.5 11.5 11.5 11.5 4.9 9.74
AfrD Niger Urban 2003 0.5 Grais et al.
53 O 767 7.2 4.2 4.2 3.9 3.9 0.7 3.90
AfrD Nigeria Urban 1992 1 Byass et al.
22 O 481 4.72 4.72 2.82 2.82 2.82 7.54
AfrD Nigeria Rural 2004 0.5 Grais et al.
53 O 1142 10.6 12.8 12.8 8.5 8.5 2.3 7.00
AfrD Senegal Rural 1982 1 Aaby
11 R 160 26.88 26.88 26.88 26.88 26.88 26.88 26.88
AfrD Senegal Rural 1986 1 Aaby
11 R 537 18.06 18.06 18.06 18.06 18.06 18.06 18.06
AfrD Senegal Rural 1991 4 Aaby et al.
12 R 624 5.52 1.41 1.41 0 0 0 3.47
1
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YAfrD Senegal Rural 1994 0.8 Cisse et al.
27 O 209 0 0 0 0 0 0 0 0.00
AfrD Senegal Rural 1983 3.8 Garenne and Aaby
32 S 1466 11.52 10.86 13.62 7.36 2.53 1.23
(to 119)
0.0
(120þ)
7.85
AfrD Senegal Rural 1985 1 Pison and Bonneuil
33 O 56 24.1 24.1 24.1 13.33 13.33 0(60–131) 18.72
AfrD Senegal Rural 1987 3.5 Samb et al.
69 S 630 2.33 5.75 0 0 1.2 0.54 1.96
AfrD Senegal Rural 1983 3.8 Samb et al.
69 S 1500 12 12 0 1 0 6.50
AfrD Sudan Urban 1997 0.4 Ibrahim et al.
55 S9 5 9.47
AfrD Sudan All 2003 0.5 Coronado et al.
56 S 523 0 0.7 0.7 0.7 0.7 0.003 0.40
AfrD Sudan Rural 2003 0.5 Coronado et al.
56 S 621 4.17 1.92 1.92 1.92 1.92 0.006 1.30
AfrD Overall 19411 7.09
AfrE Burundi Rural 1988 1.25 Chen et al.
24 S 457 7.58 7.58 2.7 2.7 2.7 5.14
AfrE DR Congo Urban 1981 1 Aaby
11 R 1069 5.99 5.99 5.99 5.99 5.99 5.99
AfrE Ethiopia Urban 1981 1 Aaby
11 R 63 26.98 26.98 26.98 26.98 26.98 26.98
AfrE Kenya Rural 1985 2.16 Burstom et al.
21 S 139 41.38 7.14 16.67 12.5 0 2.94
(60–119)
0.0
(120þ)
11.52
AfrE Kenya Rural 1987 1 Burstom et al.
20 S 252 29.27 46.15 46.15 47.5 47.5 2.94
(60–119)
0.0
(120þ)
25.17
AfrE Malawi All 1996 2 Yamaguchi et al.
51 S 542 0.93 2.76
(12þ)
2.76
(12þ)
2.76
(12þ)
2.76
(12þ)
2.76
(12þ)
1.85
AfrE Mozambique Urban 1993 2 Cliff et al.
66 S 2363 1.39
AfrE Mozambique Urban 1998 2 Cliff et al.
66 S 2720 0.147059
AfrE South Africa Rural 1980 18 Uzicanin et al.
57 S 10371 0.973869
AfrE Zambia Urban 1982 1 Aaby
11 R 316 1.9 1.9 1.9 1.9 1.9 1.9
AfrE Zimbabwe Urban 1980 10 Marufu et al.
38 S 637 12.62 13.98 0.65 0.35 6.9
AfrE Overall 18929 2.02
AmrD Peru Rural 1993 1 Sniadack et al.
50 O 150 18.75 20 3.33
AmrD Overall 150 3.33
EmrD Pakistan Rural 1990 0.16 Murray and
Rasmussen
39
O 104 2.88
(0–167)
2.88
(0–167)
2.88
(0–167)
2.88
(0–167)
2.88
(0–167)
2.88
(0–167)
2.88
(0–167)
2.88
EmrD Somalia Rural 1980 1 Aaby
11 R 6 0 022222 2 2
EmrD Overall 704 2.13
SearB Sri Lanka All 1983 1 WER
44 S 2386 1.09 1.09 1.09 1.09 1.09 1.09 1.09
SearB Sri Lanka All 1982 1.24 WER
44 S 630 1.17 1.17 1.17 1.17 1.17 1.17
SearB Sri Lanka All 1999 2 Puvimanasinghe et al.
58 O 4611 0.1
SearB Thailand Rural 1984 0.16 WER
43 O 47 33.33 33.33 33.33 33.33 33.33 18.75
(60–119)
14.29
(120þ)
22.12
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5Table 1 Continued
CFR (age in months)
WHO
sub
region Country Site
Year
study
started
Study
length
(years) Reference Type
a Total
cases 411 12–23 24–35 36–47 48–59 60 þ
Other
age Overall
SearB Overall 7674 0.64
SearD Bangladesh Urban 1983 1 WER
45 S 3026 2.25 2.13 1.8 1.42 1.95 0.39
(60–71)
0.60
(72þ)
1.51
SearD Bangladesh Rural 1980 0.5 Shahid et al.
47 S 72 1.3
(0–23)
1.3
SearD Bangladesh Rural 1980 8 Fauveau et al.
31 S 3514 3.06 2.66 1.9 1.51 0.52 0.37 1.67
SearD Bangladesh Rural 1980 1 Bhuiya et al.
19 S 3458 1.26 2.22 1.66 1.66 1.66 1.71
SearD Bangladesh Rural 1981 1 Aaby
11 R 510 3.92
(0–59)
3.92
(0–59)
3.92
(0–59)
3.92
(0–59)
3.92
(0–59)
4.15 3.92
SearD Bangladesh Rural 1989 2 DeFrancisco A et al.
28 S 2775 1.65 0.83 0.96 0.96 0.96 1.15
SearD India Rural 1974 13 Chand et al.
23 S 411 7.27 1.69 0.83
(48–179)
0.83
(48–179)
0.83
(48–179)
3.26
SearD India Rural 1979 0.9 Cherian et al.
25 O 78 9.09 27.27 16 0 0 10.47
SearD India Rural 1980 1 Singh et al.
49 R 266 3.38
SearD India Rural 1980 3 Dhanoa and Cowan
29 S 372 3.76 3.76 3.76
SearD India Rural 1980 1 Singh et al.
49 R5 5 12.73
SearD India Rural 1980 1 Aaby
11 R5 0 1 8 1 8
SearD India Rural 1982 1 Singh et al.
49 R 113 0.0
(0–119)
0.0
(0–119)
0.0
(0–119)
0.0
(0–119)
0.0
(0–119)
0.0
(0–119)
0.0
(0–119)
0
SearD India Rural 1982 1 Aaby
11 R 78 3.85 3.85 3.85 3.85 3.85 3.85
SearD India Rural 1982 1 Singh et al.
49 R 102 3.92 3.92 3.92 3.92 3.92 3.92
SearD India Rural 1983 1 Singh et al.
49 R 1 3 20000 0 0
SearD India Rural 1983 1 Singh et al.
49 R 2 4 10000 0 0.83 0.83
SearD India Rural 1983 0.41 Bhatia et al.
18 O 515 2.72
(0–179)
2.72
(0–179)
2.72
(0–179)
2.72
(0–179)
2.72
(0–179)
2.72
(0–179)
2.72
(0–179)
2.72
SearD India Rural 1984 1 Singh et al.
49 R 430 1.63 1.63 1.63 1.63 1.63 1.63
SearD India Rural 1984 1 Aaby
11 R 78 10.26 10.26 10.26 10.26 10.26 10.26
SearD India Rural 1984 1 Singh et al.
49 R 133 14.29
(0–179)
14.29
(0–179)
14.29
(0–179)
14.29
(0–179)
14.29
(0–179)
14.29
(0–179)
14.29
(0–179)
14.29
SearD India Rural 1985 1 Singh et al.
49 R 2218 3.11
(0–179)
3.11
(0–179)
3.11
(0–179)
3.11
(0–179)
3.11
(0–179)
3.11
(0–179)
3.11
(0–179)
3.11
SearD India Rural 1985 1 Singh et al.
49 R 46 23.92
(12–71)
23.92
(12–71)
23.92
(12–71)
23.92
(12–71)
23.92
(12–71)
23.92
(12–71)
23.92
1
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YSearD India Rural 1986 0.5 Narain et al.
40 O 761 23.08 11.47 11.47 11.47 11.47 5.52
(60–119)
2.03
(120–179)
10.53
SearD India Rural 1986 1 Aaby
11 R 79 5.06 5.06 5.06 5.06 5.06 0.0
(60þ)
5.06
SearD India Rural 1986 1 Singh et al.
49 R 581 0.17
(0–179)
0.17
(0–179)
0.17
(0–179)
0.17
(0–179)
0.17
(0–179)
0.17
(0–179)
0.17
(0–179)
0.17
SearD India Rural 1986 1 Singh et al.
49 R 217 5.07
(0–179)
5.07
(0–179)
5.07
(0–179)
5.07
(0–179)
5.07
(0–179)
5.07
(0–179)
5.07
(0–179)
5.07
SearD India Rural 1991 0.16 Risbud et al.
46 O 48 37.5 36.36 30.77 25 50 0 0 29.94
SearD India Rural 1992 1 Singh et al.
48 O 14522 4.1
SearD India Rural 1992 1 Singh et al.
49 R 93 8.6
(0–179)
8.6
(0–179)
8.6
(0–179)
8.6
(0–179)
8.6
(0–179)
8.6
(0–179)
8.6
(0–179)
8.6
SearD India Rural 1992 1 Risbud et al.
46 O 128 33.33 30 3.7 8.7 0 10.0
(60–71)
0
(72–119)
12.57
SearD India Rural 1993 1 Singh et al.
48 O 6392 2.39
SearD India Rural 1994 1 Singh et al.
48 O 10561 2.4
SearD India Rural 1995 1 Singh et al.
48 O 1931 3.68
SearD India Rural 1996 1 Singh et al.
48 O 6922 4.1
SearD India Urban 1980 2 Singh et al.
49 R 731 1.37
(0–179)
1.37
(0–179)
1.37
(0–179)
1.37
(0–179)
1.37
(0–179)
1.37
(0–179)
1.37
(0–179)
1.37
SearD India Urban 1985 2 Singh et al.
49 R 189 0
(0–119)
0
(0–119)
0
(0–119)
0
(0–119)
0
(0–119)
0
(0–119)
0
(0–119)
0
SearD India Urban 2003 0.30 Sharma et al.
59 O5 8 0
SearD India Urban 2003 0.1 Ratho et al.
60 O1 2 16.7
SearD India All 1999 0.1 Thakur et al.
62 S 283
SearD India Urban 1999 0.03 Ray et al.
63 S 5038
SearD Myanmar Rural 1983 1 Chin and Thanung
26 S 166 0 13.75 13.75 13.75 13.75 4.0
(60–119)
8.88
SearD Myanmar Rural 1985 1 Aaby
11 R 182 4.4 4.4 4.4 4.4 4.4 12.09
(60þ)
8.05
SearD Myanmar Rural 1985 1 Aaby
11 R 1340 3.05 3.05 3.05 3.05 3.05 0.54
(60þ)
1.8
WprA Overall 68907 2.86
WrpB Calmbodia Rural 2000 2 Oum et al.
61 S 228 1.8
WrpB Marshall Islands Rural 1982 1 Aaby
11 R 340 11.5 11.5 11.5 11.5 11.5 0 11.5
WrpB Marshall Islands All 2003 0.33 Hyde et al.
67 O 821 0 0.68 0.68 0.68 0.68 0 0 0.4
WprB Phillipines Rural 1983 1 Almoiradie–Javonillo
and Javonillo
17
O 126 6.35
(0–179)
6.35
(0–179)
6.35
(0–179)
6.35
(0–179)
6.35
(0–179)
6.35
(0–179)
6.35
(0–179)
6.25
WprB Overall 1515 3.56
aS, survey; O, outbreak; R, review.
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7India (34.31%),
11,18,23,25,29,40,46,48,49,59,60,62,63 Senegal
(7.84%)
11,12,27,32,33,69 and Guinea-Bissau
(7.84%).
11,13–16,68 Six studies each took place in
Bangladesh
11,19,28,31,45,47 and Gambia;
11,34–36 four in
Niger;
37,42,53,54 and three studies in Myanmar
(Burma),
11,26 Sri-Lanka
44,58 and Sudan.
55,56 Chad,
41,53
Ghana,
30,64 Kenya,
20,21 Marshall Islands,
11,67
Mozambique
66 and Nigeria
22,53 had two studies each.
One study each took place in Burkina-Faso,
65
Burundi,
24 Cambodia,
61 DR Congo (ex-Zaire),
11
Ethiopia,
11 Malawi,
51 Pakistan,
39 Peru,
50 Philippines,
17
Somalia,
11 South Africa,
57 Thailand,
43 Zambia
11 and
Zimbabwe.
38
The vast majority of studies were conducted in rural
areas (67.65%) with 42.0% of these (n¼29) in India.
Of the remaining studies, eight were nationally
representative [Ghana (1), Guinea-Bissau (1), India
(1), Malawi (1), Marshall Islands (1) and Sri Lanka
(3)]. Twenty-five (24.51%) of the studies were carried
out in urban areas, of which five were conducted
in urban areas of India and Guinea-Bissau, two urban
studies in Chad, Mozambique, Niger and Sudan and
one each in Bangladesh, Burkina Faso, DR-Congo
(ex-Zaire), Ethiopia, Nigeria, Zambia and Zimbabwe.
When examining studies by type, 38.24% (n¼39)
were retrospective reviews (mainly of surveillance data
from health centres), 31.37% (n¼32) were outbreak
investigations and 30.39% (n¼31) were surveys
(mainly community based—i.e. household surveys).
Case definition and definition of a measles
death
Thirty-seven studies used the WHO clinical case
definition for measles defined as any person in
whom a clinician suspects measles infection, or any
person with fever and maculopapular rash (i.e. non-
vesicular) and cough, coryza or conjunctivitis. Of
these, laboratory confirmation for a subset of cases
was available in only 14. Eight studies used parental
reporting to define measles cases. The majority of
studies (n¼49) did not explicitly define a measles
case. The remaining studies use surveillance data
collected from local health district authorities but
some do not cite a specific case definition.
Seventeen studies provided a definition of measles
death with most considering a measles death to be
any death within 6 weeks (45 days) of rash onset
excluding accidental deaths. Three studies used a
30day limit,
53,54,56 whereas another considered 60
days;
63 all four excluded accidental deaths. Two
studies employed a more restrictive definition includ-
ing deaths that occurred within 45 days of rash onset
with diarrhoea, dysentery and/or respiratory prob-
lems.
19,28 One study included cases where measles
was listed either on the death certificate or clinical
signs within 3 months of death from a parental
interview.
26 One study considered a measles death to
be any death that occurred after a measles complica-
tion (diarrhoea, pneumonia, otitis media, encephalitis
or haemorrhagic rash).
55 One study restricted measles
deaths to those within 15 days of onset of rash.
37 Two
others stated that only acute deaths from measles
were considered from death records where measles is
presumably listed as the primary cause of death
38,51
and one used only verbal autopsy.
61 One study explor-
ing the longitudinal impact of measles infection used
a wide definition, including cases that died up to
3 years after infection.
12
Case ascertainment
Most studies used reported cases of measles from
health centres or relied on parental recall. Previous
studies in areas of high measles incidence have
shown both parental and medical diagnoses to be
highly reliable.
11,13,69 However, measles can be diffi-
cult to distinguish from other rash–fever illnesses
like rubella, dengue, etc., especially in low incidence
settings where physicians are less accustomed to
seeing it.
28 Although several studies addressed the
possibility of misclassification in either parental
recall or surveillance data, quantification of this
difference was not discussed. Two sets of studies
used data from active demographic surveillance
systems in Bangladesh and Senegal. One study
aimed to assess antibody response 7 months after
a measles epidemic and used laboratory data for
measles virus haemagglutination-inhibition antibody
for case ascertainment.
26
Descriptive analysis
In total, 117336 cases and 3857 deaths (overall
CFR¼3.29) were included in the data set. The
median CFR was 3.91 (mean¼7.40, range¼
0–40.15). Figure 1 shows a histogram of the CFRs
reported for all age-groups in the 102 studies. The
sample size varied considerably with a median sample
size of 328 measles cases (mean¼1150).
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Figure 1 Histogram of overall CFRs reported by all studies
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The median CFR for outbreak investigations was 5.18
(2.56, 11.55), for reviews 3.92 (1.39, 12.73) and for
surveys 1.85 (1.17, 9.5). The minimum CFR for all
study types was 0.0 and the maximum was 40.16 for
outbreak investigations, 26.98 for reviews and 26.79
for surveys. Differences were not statistically signifi-
cant (P¼0.54).
Although across all studies there was no difference
in median CFR by study type, when we examined
only studies in rural areas, a greater difference
emerges (although not statistically significant,
P¼0.42). For outbreak studies in rural areas only,
the median CFR was 6.63 (2.88, 14.81). In reviews,
the median CFR in rural areas was 5.06 (2.0, 12.73)
and in surveys 3.51 (1.58, 8.88).
In studies that are nationally representative (n¼8),
the median CFR was 1.0 (0.23, 1.51). In studies
located in rural areas (n¼69), the median CFR was
markedly higher, up to 5.06 (2.0, 12.57, P¼0.001),
and also in urban areas (n¼25), where the median
CFR was 2.8 (1.0, 7.54, P¼0.07).
Studies with no case fatalities
Ten studies reported no fatalities.
11,27,36,49,59,62,63,68
The studies with no case fatalities had low sample
sizes (median ¼ 122.5) but similarly low sample sizes
were also seen in studies with very high CFRs (see
next section). We note, however, that minimum
sample sizes of 140 and 70 are, respectively, required
for the probability to be 450% of observing a CFR 40
when the true CFR is 0.5 or 1.0. Two studies in rural
Gambia and one study in Senegal occurred in highly
immunized population.
11,27,36 A clinical trial con-
ducted in Guineas-Bissau reported no deaths in the
vaccinated group.
68 The seven remaining studies
occurred in India where the lack of fatalities was
attributed to adequate health care facilities for
treatment of measles-associated complications.
Studies with very high CFR
Sixteen studies reported CFRs above 15.0 for all age-
groups.
11,13,14,20,30,33,35,42,43,46,49,60 Sample sizes ranged
from 12 to 961 measles cases (median¼118.5). The
majority of very high CFR studies describe outbreaks
in isolated populations. During an outbreak in
Thailand, measles spread rapidly between two villages
within walking distance of one another and cases
ranged from 7 months to 25 years.
43 A similar
epidemic occurred in a remote tribal population in
Thane district, Maharashtra, India.
46 One study points
out the high prevalence of malnutrition as a possible
explanation for the elevated mortality.
60 In the
remaining studies, vaccination coverage was extre-
mely low or the study began before the advent of
routine measles vaccination, regardless of study
location.
Risk factors
Age at infection
Across 28 studies reporting average age of infection,
there was no clear direct relationship between
CFR and age of infection or study loca-
tion.
11,14,17,20,26,32,33,35,36,40,43,51,53–56,64,66 Of these,
10/28 occurred in settings where there was no measles
immunization
11,20,26,32,35,36,51 where the average age
at infection is known to be lower. One study in
Senegal concluded that a major increase in measles
vaccination coverage increased the average age of
infection from 4 to 7 years. In the period before the
increase in vaccination coverage, 12% of cases
occurred in children under the age of 1 year compared
with 2% after. Similarly, in the period before the
increase in coverage 12% of cases were in children
between 1 and 2 years, compared with 6% in the
period after the increase in coverage. The increased
age of infection was said to have accounted for a 20%
decline in measles CFR.
69
Few studies employed age groups refined enough to
estimate CFR by single years of age for children under 5
years of age. Even fewer studies addressed case fatality
in infants (age 0–11 months).
28,31,35,38,47 Of the studies
(n¼10) that allowed for the analysis of CFRs for
children under 5 years of age, the age-specific CFR
varied considerably by age class but almost all exhibited
a decreasing trend with each year increase in age.
A slightly different pattern is seen, however, when
the data are aggregated across studies (Figure 2),
Figure 2 Notched box plot of CFR for studies with defined
age groups. In a notched box plot, the notches represent a
robust estimate of the uncertainty about the medians for
box-to-box comparison. Boxes whose notches do not over-
lap indicate that the medians of the two groups differ at the
5% significance level. The median is represented by the
horizontal line through each box
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months and 12–23 months. For ages 0–11 months the
median CFR was 16.45 (0.59, 32.3); for age 12–23
months the median CFR was16.86 (5.44,28.28);for age
24–35 months the age-specific CFR was 14.81 (6.73,
22.89); for age 36–47 months the median CFR was 8.03
( 0.86, 16.92); and for age 48–59 months the median
CFR was 2.24 ( 0.39, 4.87). Differences between age
groups were borderline P¼0.052).
Secondary vs primary case
Higher CFRs among secondary cases in several studies
were attributed to a greater dose of measles virus and
other infectious agents that secondary cases may have
received from the index case.
11,19,20,32–37 The defini-
tion of secondary case used in these studies varied.
Definition of a primary or secondary case was based
within a household,
19,20 between a household and
compound
27 or among family members.
37
Infection with complications
Mortality was associated with diarrhoea and res-
piratory complications (including pneumonia) and
otitis media and encephalitis in several stu-
dies.
11,18,20,21,23,26,31,38,40,44,47,51,53,54,58–60,62,63,67,68 Of
the studies addressing the association between com-
plications and death, respiratory complications were
more directly associated with risk of death than
diarrhoeal infections; nonetheless, one study found
pneumonia more frequently among mild measles
cases than among severe cases.
55
Immunization status
The majority of studies suggest that children with
a record of previous vaccination have a lower CFR
and reduced complications.
11–16,20,22,35,36,41,48–50,56,57,69
Milder measles disease was also associated with a
lower CFR in vaccinated children,
12–14,69 but other
studies did not find any difference.
55 One study in
Senegal suggested that the observed decrease in CFR
could be due to the increase in measles vaccination
coverage and the older age of the measles cases.
69
Two other studies examined the difference in CFR
before and after supplemental immunization cam-
paigns. Cliff et al.
66 analysed information from the
routine surveillance system on total measles cases and
deaths to compare pre- and post-supplemental vacci-
nation campaigns in five urban areas of Mozambique.
The CFR declined in Maputo, the capital city from
2.3% to 0.3% and one other urban area from 1.7% to
no deaths; remained the same in two other cities; and
increased in one area from no deaths to a CFR of
0.1% (one death reported). An additional study
exploring measles incidence before and after a mass
vaccination campaign in Burkina Faso found an
overall CFR of 1.5% after the campaign, but the CFR
pre-campaign is not reported.
65 CFR was higher
among children aged 0–4 years, but 36% of deaths
were documented among the age group that was not
offered vaccination during the national campaign.
It is also likely that unimmunized children may be
at higher risk for additional reasons, experiencing a
higher CFR due to a lack of access to care or cultural
beliefs,
18,23,26,40,53 poor underlying health status or
below the age of vaccination.
18,28,31,37
Sex
Some studies found no difference between sex and
the occurrence of respiratory complications, diarrhoea
and deaths.
38,53–55,58,64 Studies in Bangladesh, India
and Nigeria found excess measles mortality in
females.
19,23,31,53 Free diarrhoea treatment centres in
Matlab, Bangladesh appear to be used less frequently
for female children.
19 A slightly elevated adjusted
odds ratio for female sex as a risk factor for mortality
in urban Nigeria is also reported.
22
Vitamin A deficiency
One study in Bangladesh (of 25 443 children aged
0–95 months) specifically aimed to measure the
difference between measles acute case fatality and
measles-associated fatalities and vitamin A supple-
mentation, and no marked difference in acute
measles fatality between vitamin A supplemented
and placebo groups was found (15.4% vs 14.5%).
31
One study in Niger did not find either any relation-
ship between the vitamin A supplementation and the
probability of death.
54 Conversely, one study regis-
tered deaths only in those children that did not
receive vitamin A supplementation.
56 In a review of
longitudinal studies in Senegal, a reduction in post-
measles infection mortality could not be related
specifically to treatment with vitamin A.
12
Malnutrition
A review of historical studies concluded that factors,
such as overcrowding, the intensity of exposure
and patterns of disease transmission are more
important than nutritional status as risk factors for
measles mortality.
9,11,13 In another review, the data
were judged insufficient to establish an association
between nutritional status before illness and mortality
from measles.
48 In a small retrospective study in
Bangladesh, no difference was found between cases
and controls in weight-for-height and height-for-age
markers for overall nutritional status; but only 1 of
the 77 cases died, thereby making an assessment of
the influence on mortality impossible.
47 One study
in Sudan found higher risk of complicated measles
in children who were underweight but not in
those wasted or stunted.
55 In urban Nigeria, measles
cases were more likely to be malnourished at the
time of survey or death (13.9% compared with 6.5%
of controls) but no information was provided on
how malnutrition was measured.
22 Nutritional status
had no effect on susceptibility or outcome in another
study.
36 Two studies, one in Niger and one in India,
200 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYsuggested the high prevalence of malnutrition
as a plausible explanation for the high CFR.
54,60
Another study found that there may be an
increased CFR for severely malnourished children
(<60% weight by standard weight-for-height mea-
surement), but severely malnourished children
account for only a small proportion of measles
deaths.
11
Country and regional estimates of CFR
Although attempts were made to develop a model
for deriving country-specific CFRs, most of the
models were found to give implausible results.
Even for countries with data identified in this review,
the considerable degree of variation in these
studies (Figure 3) precluded using these studies, or
aggregates of these studies, as point estimates of
measles CFR.
It is not possible to conclude with certainty that
the CFR value derived in a given study reflects the
real value for an entire district or country. Based
on the findings of this review, an expert group was
constituted to categorize countries by similarity of
factors that influence CFR, and derived a set of
CFR ranges among children aged 1–4 years, for use
in determining the global burden of measles
1
(Table 2).
Discussion
To measure progress in measles mortality reduction,
refined estimates of measles and measles-associated
mortality are required. CFRs vary widely among
countries, regions, age and within the same commu-
nity in different years, making generalizations diffi-
cult. Even if a country or region has a reliable
estimate for CFR, extrapolating this value to other
years or regions can be problematic. The heterogeneity
and sparseness of the available data mean that values
for CFRs remain imprecise, resulting in an uncertainty
about the actual toll measles exacts. Moreover, the
sensitivity and specificity of definitions of measles
cases and deaths reported may vary widely within and
between studies and study groupings, such that
aggregated analyses should be interpreted with
caution.
Although our review included all published studies
meeting the inclusion criteria, only 29 countries are
represented in the data set and three countries, India,
Senegal and Guinea-Bissau, are over represented,
particularly with data drawn from demographic
surveillance sites that may not be representative of
the general population as these highly studied
populations frequently tend to be well-vaccinated
and have high access to care. Age groups, definitions
of measles cases and deaths, reporting of complica-
tions and other risk factors, sample size and data
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Figure 3 CFRs by country. The bar represents the median of all studies (n¼number of studies in the country), with the
lines representing the minimum and maximum of the studies from the country
ESTIMATING MEASLES CASE FATALITY RATIOS 201analysis varied widely among the studies reviewed.
This lack of uniformity presented barriers for data
aggregation allowing only for the description of
general trends and no further direct analyses.
Nevertheless, several overall conclusions about
measles CFRs from these studies can be drawn.
First, vaccination is associated with milder measles
and lower CFRs in most studies providing information
on vaccination status of measles cases. Second,
patterns demonstrated in the studies included in
this review suggest that higher CFRs occur in
outbreaks; children under 5 years of age; in secondary
cases; in cases with complications; and in unimmu-
nized individuals. Although the studies in this review
did not support a clear benefit of vitamin A
supplementation on mortality, other evidence sug-
gests the contrary and vitamin A supplementation is
recommended by the WHO.
70,71
This review also suggests that studies done in rural
and urban areas alone exhibited statistically signifi-
cant higher CFRs than studies covering an entire
country, likely attributable to these studies having
been done in areas of known high measles incidence,
whereas country-wide studies cover areas of both low
and high incidence.
As future studies are designed, it is important to
consider what they should include to provide the
maximum amount of information possible to better
assess mortality. An ideal CFR study should first
and foremost include the definition of a measles
case using the standard WHO case definition.
Laboratory confirmation of a small number of cases
is preferable, but not always possible in low income
settings. The definition of an acute measles death is
any death, except accidents and trauma, taking place
within 30 days of the onset of rash. Ideally, to truly
measure the burden of measles, measles-associated
deaths should be considered; that is, deaths of
measles cases due to complications or outside of the
acute measles period but within 3 months of rash
onset. When measles-associated deaths are included
in the analysis, the primary cause of death should
also be noted. In studies employing death certificates
from community health centres or hospitals, an
estimation of the percentage of deaths occurring at
home should also be reported where feasible.
A clear difficulty in obtaining better information on
CFRs is ensuring an adequate sample size. In small
outbreaks, the low sample size (number of cases
investigated) leads to wide confidence intervals.
Table 2 CFRS by region and level
CFR
range
(%) AMR EUR WPR SEAR EMR AFR
0.05 All Developed
economies
NZ, Australia,
Japan
0.1–0.5 Economies in
transition
Malaysia, Rep
Korea, Singapore,
Brunei, China,
Pacific Islands
DPRK,
Thailand,
Maldives
All others Mauritius, Swaziland
0.5–1 Philippines,
Mongolia
Bhutan, Sri
Lanka
Jordan, Egypt,
Iraq
1–2 India,
Bangladesh
Pakistan
2–3 Cambodia,
VietNam
Nepal,
Indonesia,
Timor-Leste
Djibouti,
Yemen
Malawi, South Africa, Cape Verde,
Algeria
3–4 Laos, PNG Myanmar Sudan Angola, Ethiopia, Uganda, Kenya,
Tanzania, Cameroon, Madagascar
4–5 Afghanistan,
Somalia
Chad, Congo, Nigeria, Central
African Republic, Equatorial
Guinea, Gabon, Namibia,
Sao Tome and Principe, Comoros,
Mozambique, Co ˆte d’Ivoire, Lesotho,
Rwanda, Burundi, Zambia,
Botswana, DR Congo, Niger,
Senegal, Mali, Burkina Fase,
Ghana, Eritrea
5–6 Sierra Leone, Guinea, Liberia, Togo,
Guinea-Bissau, Mauritania, Benin,
Zimbabwe, Gambia, Seychelles
AMR¼American Region, EUR¼European Region, WPR¼Western Pacific Region, SEAR¼South East Asian Region,
EMR¼Eastern Mediterranean Region, AFR¼African Region.
202 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYBy increasing the number of cases investigated the
confidence interval can be narrowed. Byass estimated
the minimum sample size required for measles
outbreak investigations to determine CFRs within
reasonable limits.
5 Comparison of CFRs between age-
groups requires larger numbers of measles cases to
adequately assess age differentials.
When reporting results, studies should completely
describe the type of data used to identify cases
(i.e. routine surveillance, household survey) and
specify the time period. Data from health centres
should specify whether cases were confirmed by a
health care worker or by a standardized case assess-
ment form. Household surveys should specify whether
an exhaustive or sample of households were assessed.
If a sample of households was assessed, an overview
of the sampling scheme should be provided along
with the definition of household used in the study.
37
As in any epidemiologic study, the potential for bias
or misclassification in ascertainment of cases and
deaths should be considered. For ethical reasons,
measles CFR studies must be retrospective by design
as it would be unethical to study prospectively
measles deaths and not intervene in the population
to vaccinate unvaccinated children or to treat measles
cases. See reference Byass
5 for further guidance on
conducting CFR studies.
Refining estimates of measles CFRs would provide
not only important information on the progress of
measles mortality reduction initiatives and burden of
disease, but also on the availability of adequate care.
Because of the high visibility of measles as a child-
hood killer, measles CFR can be used as a marker of
availability and utilization of primary health services.
7
Although current measles mortality reduction initia-
tives have made significant progress, further research
on measles CFRs is essential to accurately measure
levels of measles mortality, and particularly for
estimating the contribution that measles mortality-
reduction activities can make towards achieving
the Millennium Development of reducing child mor-
tality rates.
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